Skip to main content

Table 3 Genotype and allele prevalence of TP53 (rs1042522) polymorphism among studied groups using SNPstat software

From: Prevalence of TP53 gene Pro72Arg (rs1042522) single nucleotide polymorphism among Egyptian breast cancer patients

TP53 (rs1042522)

Healthy (n = 100)

No (%)

BC

(n = 100)

No (%)

Odds ratio

(95% CI)

P-value

Familial BC (n = 50)

No (%)

Non-familial BC (n = 50)

No (%)

Odds ratio

(95% CI)

P-value

CC (Pro/Pro)

54 (54%)

19 (19%)

1.00

 

25 (50%)

17 (34%)

1.00

 

CG (Pro/Arg)

38 (38%)

39 (39%)

0.34 (0.17–0.68)

 < 0.0001*

17 (34%)

22 (44%)

1.9 (0.79–4.6)

0.27

GG (Arg/Arg)

8 (8%)

42 (42%)

0.07 (0.03–0.17)

 < 0.0001*

8 (16%)

11 (22%)

2.02 (0.67–6.07)

0.27

CG (Pro/Arg) + GG (Arg/Arg)

46 (46%)

81 (81%)

0.2 (0.11–0.38)

 < 0.0001*

25 (50%)

33 (66%)

1.48 (0.54–4.06)

0.14

TP53 alleles

C

146 (73%)

77 (38%)

 

0.01*

33 (33%)

44 (44%)

 

0.16

G

54 (27%)

123 (62%)

 

67 (67%)

56 (56%)

Â